AwesomeCapital
Search This Blog
Saturday, September 15, 2018
Circulation Article Paints Positive Risk Benefit for Alnylam’s Onpattro – Cowen
Cowen analyst Ritu Baral weighed in on Alnylam Pharmaceuticals (NASDAQ: ALNY) after Onpattro APOLLO cardiac subpopulation data was published
https://www.streetinsider.com/Analyst+Comments/Circulation+Article+Paints+Positive+Risk+Benefit+for+Alnylams+%28ALNY%29+Onpattro+-+Cowen/14609905.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.